Clinical Trials Insight: 700024908
Phase of Trial: Phase III
Latest Information Update: 21 Jan 2017
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Irinotecan
- Indications Gastric cancer
- Focus Therapeutic Use
- 21 Jan 2017 Results (n=1248) of a combined analysis from SPIRITS, TOP-002 and START trials, presented at the 2017 Gastrointestinal Cancers Symposium
- 18 Jan 2014 Results of a predictive biomarker analysis presented at the 2014 Gastrointestinal Cancers Symposium.
- 31 May 2009 Results presented at ASCO 2009.